(Q48215898)

9 February 2018

title

Evaluation of the effects of radiotherapy on macroprolactinomas using the decline rate of serum prolactin levels as a dynamic parameter (English)

1 reference

9 February 2018

Adaptive radiation therapy

main subject

0 references

author name string

M Williams

1

1 reference

9 February 2018

A P van Seters

2

1 reference

9 February 2018

J Hermans

3

1 reference

9 February 2018

J W Leer

4

1 reference

9 February 2018

publication date

1 January 1994

1 reference

9 February 2018

published in

Clinical Oncology

1 reference

9 February 2018

volume

6

1 reference

9 February 2018

issue

2

1 reference

9 February 2018

page(s)

102-109

1 reference

9 February 2018

Galactorrhea-Amenorrhea Syndrome: Diagnosis and Therapy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980112-8

7 January 2021

Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980112-8

7 January 2021

Cushing's disease revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980112-8

7 January 2021

Decreased bone density in hyperprolactinemic women

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980112-8

7 January 2021

Vertebral body bone mineral content in hyperprolactinemic women

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980112-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980112-8

1 reference

7 January 2021

Long-term results of transsphenoidal pituitary microsurgery in 60 acromegalic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980112-8

7 January 2021

The interaction of growth hormone releasing hormone with other hypothalamic hormones on the release of anterior pituitary hormones.

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980112-8

7 January 2021

Growth of males with idiopathic hypopituitarism without growth hormone treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980112-8

7 January 2021

Somatomedin-C levels in treated and untreated patients with acromegaly.

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980112-8

7 January 2021

Bromocriptine therapy for non-functioning pituitary adenoma

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980112-8

7 January 2021

Therapeutic irradiation and brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980112-8

7 January 2021

Treatment of prolactinomas with megavoltage radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980112-8

7 January 2021

The long-term effects of megavoltage radiotherapy as sole or combined therapy for large prolactinomas: studies with high definition computerized tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980112-8

7 January 2021

Megavoltage pituitary irradiation in the management of prolactinomas: long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980112-8

7 January 2021

Radiation therapy of pituitary tumors: results in 95 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980112-8

7 January 2021

Hyperprolactinaemia after external irradiation for acromegaly

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980112-8

7 January 2021

Radiation-induced hypopituitarism is dose-dependent

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980112-8

7 January 2021

Management of prolactinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980112-8

7 January 2021

Long term follow-up of women with surgically treated prolactin-secreting pituitary tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980112-8

7 January 2021

Drugs five years later. Bromocriptine

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980112-8

7 January 2021

Rapid Changes of Prolactinoma Volume after Withdrawal and Reinstitution of Bromocriptine*

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980112-8

7 January 2021

Effect of dopamine agonist withdrawal after long-term therapy in prolactinomas. Studies with high-definition computerised tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980112-8

7 January 2021

Long-term treatment of hyperprolactinaemia with bromocriptine: effect of drug withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980112-8

7 January 2021

Withdrawal of bromocriptine after long-term therapy for macroprolactinomas; effect on plasma prolactin and tumour size

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980112-8

7 January 2021

Resistance to bromocriptine in prolactinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980112-8

7 January 2021

Treatment of Cushing's disease with low dose radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980112-8

7 January 2021

Hyperprolactinemic response after bromocriptine withdrawal in women with prolactin-secreting pituitary tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980112-8

7 January 2021

UNILATERAL ADRENALECTOMY FOLLOWED BY PITUITARY IRRADIATION IN CUSHING'S DISEASE; WITH OBSERVATIONS ON CORTISOL SECRETION AFTER THERAPY

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980112-8

7 January 2021

Megavoltage pituitary irradiation in the management of Cushing's disease and Nelson's syndrome: long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980112-8

7 January 2021

Effects of prolactin and estrogen deficiency in amenorrheic bone loss

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980112-8

7 January 2021

10.1016/S0936-6555(05)80112-8

Identifiers

DOI

1 reference

9 February 2018

1 reference

9 February 2018